dronabinol has been researched along with gw 1000 in 222 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 20 (9.01) | 29.6817 |
| 2010's | 157 (70.72) | 24.3611 |
| 2020's | 45 (20.27) | 2.80 |
| Authors | Studies |
|---|---|
| Szendrei, K | 1 |
| Smith, PF | 1 |
| Berman, JS; Birch, R; Symonds, C | 1 |
| Sibbald, B | 1 |
| Lee, MC; Menon, DK | 1 |
| Blake, DR; Ho, M; Jubb, RW; McCabe, CS; Robson, P | 1 |
| Barnes, MP | 1 |
| Guy, G; Ware, M; Wright, S | 1 |
| D'Arcy, Y | 2 |
| Scully, C | 1 |
| Guy, GW; Robson, PJ; Russo, EB | 1 |
| Grotenhermen, F | 1 |
| Haines, D; Hoggart, B; Morlion, BJ; Nurmikko, TJ; Serpell, MG; Toomey, PJ | 1 |
| Nurmikko, TJ; Rog, DJ; Young, CA | 1 |
| Perez, J; Ribera, MV | 1 |
| Pertwee, RG | 1 |
| Bereza, B; Desjardins, O; Einarson, TR; Iskedjian, M; Jaszewski, B; Piwko, C | 1 |
| Bari, M; Battistini, L; Bernardi, G; Buttari, F; Cencioni, MT; Centonze, D; Codecà, C; Fiore, S; Koch, G; Maccarrone, M; Mori, F; Rossi, S | 1 |
| Emery, CJ; Gandhi, R; Selvarajah, D; Tesfaye, S | 1 |
| Alsindi, Z; Ambler, Z; Collin, C; Davies, P; Ehler, E; Notcutt, W; Nováková, I; O'Leary, C; Piková, J; Powell, K; Ratcliffe, S; Waberzinek, G; Zapletalova, O | 1 |
| Collin, C; Duncombe, P; Stott, C; Wade, DT | 1 |
| Kmietowicz, Z | 1 |
| Bernardi, G; Buttari, F; Centonze, D; Codecà, C; Fiore, S; Koch, G; Kusayanagi, H; Monteleone, F; Mori, F | 1 |
| Constantinescu, CS; De Ridder, D; Fowler, CJ; Kavia, RB; Stott, CG | 1 |
| Darwin, WD; Goodwin, RS; Huestis, MA; Karschner, EL; Wright, S | 1 |
| Darwin, WD; Goodwin, RS; Huestis, MA; Karschner, EL; Liu, F; McMahon, RP; Wright, S | 1 |
| Gross, H | 1 |
| Ambler, Z; Cefaro, L; Comi, G; Davies, P; Erdmann, A; Gasperini, C; Klimek, A; Mares, J; Montalban, X; Novakova, I; Novotna, A; Pozzilli, C; Ratcliffe, S; Rossi, P; Stelmasiak, Z; Vachova, M; Zapletalova, O | 1 |
| Haas, J | 1 |
| Di Marzo, V | 1 |
| Vermersch, P | 2 |
| Clissold, S; Montalban, X; Sastre-Garriga, J; Vila, C | 1 |
| Robson, P | 1 |
| Chen, N; Guy, G; Hilliard, A; Romach, MK; Russo, E; Schoedel, KA; Sellers, EM; Stott, C; White, L; Wright, S | 1 |
| Fernández-Ruiz, J; Pazos, MR; Pertwee, RG; Ramos, JA; Sagredo, O; Satta, V | 1 |
| Solaro, C | 1 |
| Davies, P; Langford, R; Notcutt, W; Potts, R; Ratcliffe, S | 1 |
| Brower, V | 1 |
| Oreja-Guevara, C | 2 |
| Wade, D | 1 |
| Gras, A; Slof, J | 1 |
| Antonino de la Camara, G; Dominguez Moran, JA; García del Busto, N; Garcia-Llopis, P; Lopez Tinoco, MJ; Mejia Andujar, L; Peiro Vilaplana, C; Quintana Vergara, B; Sánchez Alcaraz, A; Vicente-Valor, MI | 1 |
| Notcutt, WG | 1 |
| Fernández-Ruiz, J; Pertwee, RG; Sagredo, O; Satta, V; Valdeolivas, S | 1 |
| Collin, C; Notcutt, W; Serpell, MG | 1 |
| Constantinescu, CS; Podda, G | 1 |
| Altman, DG; Duncombe, P; Wright, S | 1 |
| Lang, IA; Lu, L; Pearce, H; Roome, C; Shearer, J; Stein, K | 1 |
| Barnes, AJ; Goodwin, RS; Huestis, MA; Karschner, EL; Lee, D; Milman, G | 1 |
| Guy, GW; Stott, CG; White, L; Wilbraham, D; Wright, S | 1 |
| Gramstad, L; Sagabråten, AS | 1 |
| Trojano, M | 3 |
| García-Merino, A | 1 |
| Flachenecker, P | 2 |
| Florek, E; Piekoszewski, W; Tkaczyk, M | 1 |
| Casarejos, MJ; de Yebenes, JG; Fernandez Ruiz, J; Fernandez-Estevez, M; Gomez, A; Guzman, M; Mena, MA; Muñoz, MP; Perucho, J; Sagredo, O | 1 |
| Constantinescu, CS; Tanasescu, R | 1 |
| Cesar-Rittenberg, P; Hohmann, AG; Lynch, ME | 1 |
| Amato, MP; Koehler, J; Lycke, J; Oreja-Guevara, C | 1 |
| Allsop, DJ; Booth, J; Copeland, J; Dunlop, AJ; Holland, RM; Lintzeris, N; McGregor, IS; Montebello, M; Muhleisen, P; Norberg, MM; Rivas, GR; Sadler, C | 1 |
| Pozzilli, C | 1 |
| Rekand, T | 1 |
| Koehler, J | 1 |
| Flachenecker, P; Henze, T; Zettl, UK | 2 |
| Erbe, B | 1 |
| Barnes, AJ; Huestis, MA; Scheidweiler, KB | 1 |
| McKeage, K; Scott, LJ; Syed, YY | 1 |
| Allsop, DJ; Copeland, J; Fu, S; Lewis, J; Molnar, A | 1 |
| Benyamina, A; Reynaud, M | 1 |
| de Lago, E; Espejo-Porras, F; Fernández-Ruiz, J; Moreno-Martet, M | 1 |
| Essner, U; Freidel, M; Lang, M; Prechtl, A; Schreiber, H; Tiel-Wilck, K | 1 |
| Arie, S; Mahony, C | 1 |
| Arroyo, R; Dechant, KL; Vila, C | 1 |
| Centonze, D | 1 |
| Fernández, O | 3 |
| Celius, EG; Donzé, C; Izquierdo, G; Patti, F; Pöhlau, D; Trojano, M | 1 |
| Garcia-Merino, A; Moreno Torres, I; Sanchez, AJ | 1 |
| Kramer, JL | 1 |
| Armstrong, JL; Babatunde, F; Corazzari, M; Eleni Anagnostou, M; Hernandez-Tiedra, S; Hill, DS; Lopez-Valero, I; Lorente, M; Lovat, PE; McKee, CS; Redfern, CPF; Velasco, G | 1 |
| Bramanti, P; Calabrò, RS; D'Aleo, G; De Luca, R; Leo, A; Naro, A; Quartarone, A; Rifici, C; Russo, M; Sessa, E | 1 |
| Cimas-Hernando, I; Lorenzo-González, JR; Pato-Pato, A; Rodríguez-Constenla, I | 1 |
| Ruiz, L; Slof, J; Vila, C | 1 |
| Allsop, DJ; Copeland, J; Dunlop, A; Lintzeris, N; McGregor, IS | 1 |
| Lebrun, C; Vermersch, P | 1 |
| Carrillo-Salinas, FJ; de Lago, E; Feliú, A; Fernández-Ruiz, J; Guaza, C; Mecha, M; Moreno-Martet, M | 1 |
| Bramanti, P; Calabrò, RS; D'Aleo, G; Rifici, C; Russo, M; Sessa, E | 1 |
| Laprevote, V; Rolland, B; Schwan, R; Schwitzer, T; Thome, J | 1 |
| Dechant, KL; Meuth, SG; Vila, C | 1 |
| Cocco, E; Coghe, G; Corona, F; Fenu, G; Frau, J; Lorefice, L; Mamusa, E; Marrosu, MG; Massa, R; Massole, S; Musu, L; Pau, M; Spinicci, G | 1 |
| Amadio, S; Comi, G; Del Carro, U; Houdayer, E; Leocani, L; Martinelli, V; Nuara, A; Rossi, P; Schiavetti, I; Sormani, MP; Straffi, L; Vila, C | 1 |
| Pain, S | 1 |
| Owens, B | 1 |
| Colombo, B; Comi, G; Esposito, F; Ferrè, L; Keller Sarmiento, IJ; Leocani, L; Martinelli Boneschi, F; Martinelli, V; Moiola, L; Nuara, A; Pavan, G; Radaelli, M; Rodegher, M | 1 |
| Bazinski, H; Jensen, HB; Stenager, E | 1 |
| Trojano, M; Vila, C | 1 |
| Carrillo-Salinas, FJ; de Lago, E; Espejo-Porras, F; Feliú, A; Fernández-Ruiz, J; Guaza, C; Mecha, M; Moreno-Martet, M | 1 |
| Bramanti, P; Calabrò, RS; D'Aleo, G; Leo, A; Naro, A; Russo, M; Sessa, E | 1 |
| Ablin, J; Fitzcharles, MA; Häuser, W; Schäfer, M; Ste-Marie, PA | 1 |
| Patti, F | 2 |
| Barnes, AJ; Fischer, B; Gamaleddin, I; Huestis, MA; Lagzdins, D; Le Foll, B; Rehm, J; Selby, P; Trigo, JM | 1 |
| Abbruzzese, G; Bandini, F; Canneva, S; Capello, E; Colombano, F; Currà, A; Fattapposta, F; Marinelli, L; Mori, L; Trompetto, C | 1 |
| Fu, S; Molnar, A | 1 |
| Barbera, N; Indorato, F; Ledda, C; Liberto, A; Romano, G | 1 |
| Alonso Arias, MA; Fernández Ruiz, J; Galve-Roperh, I; García Caldentey, J; García de Yébenes Prous, J; García de Yébenes, MJ; García Ribas, G; García-Bermejo, ML; Guzmán, M; López-Sendón Moreno, JL; Ortega-Gutierrez, S; Resel, E; Ruiz Romero, C; Sagredo, O; Tolón, RM; Trigo Cubillo, P; Valdeolivas, S | 1 |
| Álvarez-Ossorio, L; Haupts, M; Jonas, A; Vila, C; Witte, K | 1 |
| Amato, MP; Bergamaschi, R; Bonavita, S; Brescia Morra, V; Bruno Bossio, R; Cavalla, P; Centonze, D; Comi, G; Costantino, GF; Cottone, S; Danni, M; Francia, A; Gajofatto, A; Gasperini, C; Ghezzi, A; Iudice, A; Lus, G; Maniscalco, GT; Marrosu, MG; Matta, M; Messina, S; Mirabella, M; Montanari, E; Patti, F; Pozzilli, C; Rovaris, M; Sessa, E; Solaro, C; Spitaleri, D; Trojano, M; Valentino, P; Zappia, M | 1 |
| Comi, G; Gold, R; Hartung, HP; Montalban, X; Otero-Romero, S; Sastre-Garriga, J; Soelberg Sørensen, P; Thompson, AJ; Vermersch, P | 1 |
| ElSohly, MA; Gul, W; Harris, HM; Sufka, KJ | 1 |
| Gajofatto, A | 1 |
| Bramanti, P; Calabrò, RS; De Luca, R; Naro, A; Rifici, C; Russo, M; Sessa, E; Torrisi, M | 1 |
| Brunetti, A; Carotenuto, A; Cerillo, I; Cocozza, S; Inglese, M; Iodice, R; Manganelli, F; Orefice, G; Petracca, M; Saiote, C; Tedeschi, E | 1 |
| Brescia Morra, V; Carotenuto, A; Florio, EB; Lanzillo, R; Massarelli, M; Pane, C; Saccà, F | 1 |
| Bird, R; Evans, L; Trainor, D | 1 |
| Trojano, M; Vermersch, P | 1 |
| Deotto, L; Donato, F; Erro, R; Moretto, G; Squintani, G; Teatini, F; Turri, M | 1 |
| Filli, L; Ghezzi, A; Landete, L; Lycke, J; Mekies, C; Solaro, C | 1 |
| Ghezzi, A | 1 |
| Russo, EB | 1 |
| Friedman, D; Gaston, TE | 1 |
| Friedman, D; Sirven, JI | 1 |
| Allendorfer, JB; Szaflarski, JP | 1 |
| Devinsky, O; Gloss, D; O'Connell, BK | 1 |
| Jouanjus, E; Wolff, V | 1 |
| Casas, M; Centonze, D; Henze, T; Maccarrone, M; Maldonado, R | 1 |
| Keating, GM | 1 |
| Androvicova, R; Balikova, M; Hlinka, J; Hlozek, T; Horacek, J; Jezova, D; Kuchar, M; Miksatkova, P; Palenicek, T; Roman, M; Rydlo, J; Tintera, J; Tomicek, P; Tyls, F; Viktorinova, M | 1 |
| Alabajos-Cea, A; Manez-Anon, I; Montalva-Iborra, A; Roda-Alcayde, C | 1 |
| Hasselstrøm, JB; Sørensen, LK | 1 |
| Bianco, A; De Fino, C; Losavio, F; Lucchini, M; Mirabella, M; Nociti, V; Sabino, A; Santoro, M | 1 |
| Bergamaschi, R; Bonavita, S; Bossio, RB; Brescia Morra, V; Castelli, L; Cavalla, P; Centonze, D; Comi, G; Costantino, G; Cottone, S; Danni, MC; Francia, A; Gajofatto, A; Gasperini, C; Granata, A; Maniscalco, GT; Matta, M; Messina, S; Mirabella, M; Paolicelli, D; Patti, F; Pedà, G; Petrucci, L; Righini, I; Rovaris, M; Sessa, E; Signoriello, E; Solaro, C; Spinicci, G; Spitaleri, D; Zaffaroni, M; Zappia, M | 1 |
| Zhu, YP | 1 |
| Abbruzzese, G; Balestrino, M; Currà, A; Fattapposta, F; Gandolfo, C; Giorello, L; Marinelli, L; Mori, L; Puce, L; Rosa, GM; Serrati, C; Trompetto, C | 1 |
| Fallon, MT; Kornyeyeva, E; Lichtman, AH; Lux, EA; McQuade, R; Rossetti, S; Sanchez, R; Sun, W; Wright, S | 1 |
| Giner-Pascual, M; Gonzalez, LM; Grao-Castellote, C; Torralba-Collados, F | 1 |
| Aviram, J; Samuelly-Leichtag, G | 1 |
| Bramanti, P; Giacoppo, S; Mazzon, E | 1 |
| Atsmon, J; Deutsch, F; Deutsch, L; Heffetz, D; Sacks, H | 1 |
| Balíková, M; Hložek, T; Horsley, RR; Kadeřábek, L; Kuchař, M; Lhotková, E; Nováková, P; Páleníček, T; Šíchová, K; Štefková, K; Tylš, F; Uttl, L | 1 |
| Häuser, W; Krcevski-Skvarc, N; Wells, C | 1 |
| Bramanti, A; Bramanti, P; Calabrò, RS; Ciurleo, R; Dattola, V; De Luca, R; Logiudice, AL; Naro, A; Russo, M; Sessa, E | 1 |
| Atsmon, J; Cherniakov, I; Deutsch, F; Deutsch, L; Domb, AJ; Heffetz, D; Hoffman, A; Izgelov, D; Sacks, H | 1 |
| MacCallum, CA; Russo, EB | 1 |
| Barnes, AJ; Fischer, B; George, TP; Huestis, MA; Le Foll, B; Quilty, LC; Rehm, J; Selby, P; Soliman, A; Staios, G; Streiner, DL; Trigo, JM | 1 |
| Cosenza, A; Di Gaudio, F; Fanara, S; Maida, CM; Piscionieri, D; Viviani, G | 1 |
| Buckley, N; Degenhardt, L; Farrell, M; Germanos, R; Hall, W; Nielsen, S; Pollard, J; Weier, M | 1 |
| Asbridge, M; Brubacher, JR; Chan, H; Erdelyi, S; Mann, RE; Purssell, RA; Solomon, R | 1 |
| Benigni, F; Clarelli, F; Comi, G; Esposito, F; Ferrè, L; Martinelli Boneschi, F; Martinelli, V; Mascia, E; Osiceanu, AM; Sorosina, M; Unal, NT | 1 |
| Castelli, L; Pozzilli, C; Prosperini, L | 1 |
| Djamshidian, A; Heim, B; Lücke, T; Peball, M; Saft, C; Seppi, K; Thiels, C; von Hein, SM | 1 |
| Constantinescu, CS; Gershkovich, P | 1 |
| Cantello, R; Danni, MC; Lus, G; Rini, A; Sarchielli, P; Signoriello, E; Tassinari, T | 1 |
| Celius, EG; Vila, C | 1 |
| Allsop, DJ; Bhardwaj, AK; Bruno, R; Copeland, J; Dunlop, A; Gugusheff, J; Jackson, M; Lintzeris, N; Luksza, J; McGregor, IS; Montebello, M; Phung, N; Sadler, C; Shanahan, M | 1 |
| Akmaz, B; Essner, U; Lentschat, A; Marinelli, M; Markovà, J; Trompke, C; Vila, C | 1 |
| Daniel, RT; Maduri, R; Messerer, M; Pralong, E | 1 |
| Cameron, M; Rice, J | 1 |
| Bramness, JG; Dom, G; Gual, A; Mann, K; Wurst, FM | 1 |
| Comi, G; Comola, M; Falzone, Y; Fazio, R; Ferraro, OE; Leocani, L; Lunetta, C; Mora, G; Riva, N; Sorarù, G | 1 |
| de Visser, M | 1 |
| Ziemssen, T | 1 |
| Marková, J | 1 |
| Alessi-Severini, S; Alkabbani, W; Bolton, JM; Bugden, S; Daeninck, P; Leong, C; Marrie, RA | 1 |
| Bianco, A; Castelli, L; Centonze, D; Cortese, A; Crisafulli, SG; De Giglio, L; Galgani, S; Grimaldi, AE; Haggiag, S; Marfia, G; Mirabella, M; Monteleone, F; Pozzilli, C; Prosperini, L | 1 |
| Domb, AJ; Hoffman, A; Itin, C | 1 |
| Drew, L | 1 |
| Bisogno, T; Cristino, L; Di Marzo, V | 1 |
| Levin, FR; Mariani, JJ | 1 |
| Kleinman, RA; Ostacher, MJ | 1 |
| Bruno, R; Copeland, J; Lintzeris, N | 1 |
| Cross, HJ; Pietrafusa, N; Specchio, N | 1 |
| Hudnall, MT; Nadler, RB; Pham, MN | 1 |
| Essner, U; Henze, T; Meuth, SG; Trompke, C; Vila Silván, C | 1 |
| Brescia Morra, V; Carotenuto, A; Costabile, T; De Angelis, M; De Lucia, M; Falco, F; Lanzillo, R; Moccia, M; Petruzzo, M; Russo, CV; Saccà, F | 1 |
| Cortesi, PA; Cozzolino, P; Mantovani, LG; Patti, F | 1 |
| Alibhai, SMH; Clarke, H; Dai, T; Downar, J; Hanlon, JG; Meng, H | 1 |
| Checketts, D; Fairhurst, C; Kumar, R; Tayo, B; Turner, S | 1 |
| Balletta, T; Bramanti, P; Calabrò, RS; Ciurleo, R; D'Aleo, G; Destro, M; La Via, C; Naro, A; Rifici, C; Russo, M; Sessa, E | 1 |
| Carra, A; Fragoso, YD; Macias, MA | 1 |
| Alessandria, G; Bandini, F; Capello, E; Infante, MT; Meli, R; Vestito, L | 1 |
| Hall, W; Nielsen, S | 1 |
| Cantello, R; Naldi, P; Spagarino, A; Varrasi, C; Vecchio, D; Virgilio, E | 1 |
| Annunziata, P; Bergamaschi, R; Bianco, A; Bonavita, S; Brescia Morra, V; Bruno Bossio, R; Capello, E; Castelli, L; Cavalla, P; Centonze, D; Chisari, CG; Costantino, G; Cottone, S; Danni, MC; Esposito, F; Gajofatto, A; Gasperini, C; Guareschi, A; Lanzillo, R; Lus, G; Maniscalco, GT; Matta, M; Paolicelli, D; Patti, F; Petrucci, L; Pontecorvo, S; Righini, I; Rovaris, M; Sessa, E; Solaro, C; Spinicci, G; Spitaleri, D; Valentino, P; Zaffaroni, M; Zappia, M | 1 |
| Bhardwaj, A; Bruno, R; Copeland, J; Dunlop, A; Hall, M; Jefferies, M; Kevin, R; Kirby, A; Lintzeris, N; Mcgregor, I; Mills, L; Montebello, M | 1 |
| Charipova, K; Cornett, E; Gress, K; Habib, K; Jung, JW; Kassem, H; Kaye, AD; Lee, C; Lee, D; Paladini, A; Urits, I; Varrassi, G; Viswanath, O | 1 |
| Jones, É; Vlachou, S | 1 |
| Dumont, GJH | 1 |
| Dykukha, I; Essner, U; Malessa, R; Überall, MA | 1 |
| Aguirre Dávila, L; Guizzaro, L; Koch, A; Lasch, F; Müller-Vahl, K | 1 |
| Brazil, L; Checketts, D; Jove, M; Miller, S; Sabel, M; Short, SC; Tayo, B; Twelves, C | 1 |
| de Paula, BHR; Doherty, GJ | 1 |
| Paul, F; Silván, CV | 1 |
| Bosco, A; Bratina, A; Dinoto, A; Manganotti, P; Mazzon, G; Morelli, ME; Pasquin, F; Sartori, A; Stragapede, L | 1 |
| Prieto González, JM; Vila Silván, C | 1 |
| Elsner, K; Germerott, T; Hess, C; Röhrich, J; Scheunemann, A; Zörntlein, S | 1 |
| De Blasiis, P; Fullin, A; Lus, G; Melone, MAB; Sampaolo, S; Sansone, M; Siani, MF; Signoriello, E | 1 |
| Estévez-Carrillo, A; Oppe, M; Ortín-Sulbarán, D; Ramos-Goñi, JM; Vila Silván, C | 1 |
| D'haeseleer, M; D'hooghe, M; Delvaux, V; Guillaume, D; Laureys, G; Nagels, G; Popescu, V; Van Pesch, V; Vanderdonckt, P; Willekens, B | 1 |
| Lobsien, E; Schwittay, MA; Steinbrecher, A | 1 |
| Essner, U; Mueller-Schwefe, GHH; Ueberall, MA; Vila Silván, C | 1 |
| Bramness, JG; Hjellvik, V; Skurtveit, S; Stubhaug, A | 1 |
| Conte, A; Vila Silván, C | 1 |
| Bruno, R; Copeland, J; Dunlop, A; Jackson, MA; Jefferies, M; Lintzeris, N; McGregor, I; Mills, L; Montebello, M; Rivas, C; Silsbury, C | 1 |
| Chan, A; Silván, CV | 1 |
| Adjamian, P; Bagul, M; Carod-Artal, FJ; Gasperini, C; Vila Silván, C | 1 |
| Chisari, CG; Fernández, Ó; Ferrer-Picón, E; Hernández Vicente, F; Patti, F; Sarroca, J; Vila Silván, C | 1 |
| Bagetta, G; Boccella, S; Corasaniti, MT; Guida, F; Luongo, L; Maione, S; Nicotera, P; Scuteri, D; Tonin, P | 1 |
| Bruno, R; Copeland, J; Dunlop, A; Jefferies, M; Lintzeris, N; Mcgregor, I; Mills, L; Montebello, M | 1 |
| Benedetti, MD; Calabrese, M; Cardobi, N; Gajofatto, A; Gobbin, F; Turatti, M | 1 |
| Berwaerts, J; Checketts, D; Chinnapongse, R; Javaid, S; Klineova, S; Lublin, F; Nicholas, J; Steinerman, JR | 1 |
| Bunduc, S; Csupor, D; Fehérvári, P; Gergő, D; Hegyi, P; Horváth, IL; Kleiner, D; Lugosi, K | 1 |
66 review(s) available for dronabinol and gw 1000
| Article | Year |
|---|---|
[A novel analgesics made from Cannabis].
Topics: Analgesics; Arachidonic Acids; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Drugs, Investigational; Endocannabinoids; Europe; Humans; Multiple Sclerosis; Pain; Plant Extracts; Polyunsaturated Alkamides | 2004 |
Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain.
Topics: Analgesics; Cannabidiol; Cannabinoids; Dronabinol; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic; Self Administration; Sleep Wake Disorders | 2006 |
Latest pain relief a combination of new and old.
Topics: Cannabidiol; Carbazoles; Delayed-Action Preparations; Dronabinol; Drug Combinations; Humans; Nurse Practitioners; Pain; Plant Extracts; Serotonin Receptor Agonists; Tryptamines | 2007 |
Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.
Topics: Cannabidiol; Cannabis; Clinical Trials as Topic; Dronabinol; Drug Combinations; Humans; Pain; Phytotherapy; Plant Extracts; Plant Preparations; Sleep; Sleep Wake Disorders | 2007 |
The toxicology of cannabis and cannabis prohibition.
Topics: Animals; Blood Pressure; Cannabidiol; Cannabis; Cognition; Dronabinol; Drug Combinations; Heart Rate; Humans; Legislation, Drug; Marijuana Abuse; Plant Extracts; Psychomotor Performance; Risk Assessment | 2007 |
Managing neuropathic pain with Sativex: a review of its pros and cons.
Topics: Analgesics; Cannabidiol; Chronic Disease; Clinical Trials as Topic; Dronabinol; Drug Combinations; Humans; Neuralgia; Pain Measurement; Plant Extracts | 2008 |
Emerging strategies for exploiting cannabinoid receptor agonists as medicines.
Topics: Blood-Brain Barrier; Cannabidiol; Dronabinol; Drug Combinations; Drug Interactions; Humans; Ligands; Plant Extracts; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2009 |
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Pain Measurement; Plant Extracts; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2010 |
Pathophysiology, assessment and management of multiple sclerosis spasticity: an update.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Reproducibility of Results; Self Report; Severity of Illness Index | 2011 |
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction.
Topics: Animals; Cannabidiol; Disease Models, Animal; Dronabinol; Drug Combinations; Endocannabinoids; Mice; Multiple Sclerosis; Muscle Spasticity; Muscle, Skeletal; Plant Extracts | 2011 |
Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Endocannabinoids; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Quality of Life; Treatment Outcome | 2011 |
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis.
Topics: Administration, Mucosal; Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic | 2011 |
Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine.
Topics: Cannabidiol; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Combinations; Humans; Marijuana Abuse; Multiple Sclerosis; Plant Extracts; Psychotropic Drugs; Randomized Controlled Trials as Topic; Substance-Related Disorders | 2011 |
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity.
Topics: Cannabidiol; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Quality of Life; Spain | 2012 |
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough?
Topics: Cannabidiol; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drug Tolerance; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Psychotropic Drugs | 2012 |
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.
Topics: Analgesics; Animals; Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Treatment Outcome; Urologic Diseases | 2012 |
[Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids].
Topics: Administration, Sublingual; Cannabidiol; Clinical Trials, Phase III as Topic; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Legislation, Drug; Multicenter Studies as Topic; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts; Powders; Randomized Controlled Trials as Topic; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Retrospective Studies; Spain; Treatment Outcome | 2012 |
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach.
Topics: Bias; Cannabidiol; Clinical Trials, Phase III as Topic; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Linear Models; Marijuana Smoking; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents; Plant Extracts; Randomized Controlled Trials as Topic; Research Design; Self Report; Severity of Illness Index; Treatment Outcome | 2012 |
What place for ▾ cannabis extract in MS?
Topics: Adult; Cannabidiol; Cost-Benefit Analysis; Dronabinol; Drug Combinations; Drug Costs; Drug Interactions; Humans; Meta-Analysis as Topic; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain.
Topics: Anti-Dyskinesia Agents; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Modulators; Clinical Trials, Phase III as Topic; Cost of Illness; Dronabinol; Drug Combinations; Drug Resistance; Drugs, Investigational; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Practice Patterns, Physicians'; Quality of Life; Randomized Controlled Trials as Topic; Spain; United Kingdom | 2013 |
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany.
Topics: Anti-Dyskinesia Agents; Attitude of Health Personnel; Attitude to Health; Cannabidiol; Cannabinoid Receptor Agonists; Cost-Benefit Analysis; Dronabinol; Drug Combinations; Drug Costs; Drug Resistance; Germany; Health Care Costs; Humans; Multiple Sclerosis; Muscle Spasticity; Physicians; Plant Extracts; Quality of Life | 2013 |
[Marihuana and cannobinoids as medicaments].
Topics: Arthritis, Rheumatoid; Cannabidiol; Cannabinoids; Cannabis; Contraindications; Dronabinol; Drug Combinations; Humans; Inflammatory Bowel Diseases; Multiple Sclerosis; Muscle Spasticity; Nausea; Nervous System Diseases; Pain; Plant Extracts; Vomiting | 2012 |
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain.
Topics: Analgesics; Canada; Cannabidiol; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drug Evaluation, Preclinical; Humans; Multiple Sclerosis; Neuralgia; Plant Preparations; Randomized Controlled Trials as Topic | 2013 |
Clinical case reviews in multiple sclerosis spasticity: experiences from around Europe.
Topics: Adult; Aged; Cannabidiol; Dronabinol; Drug Combinations; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Treatment Outcome | 2013 |
THC:CBD spray and MS spasticity symptoms: data from latest studies.
Topics: Affect; Automobile Driving; Cannabidiol; Clinical Trials as Topic; Cognition; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Parasympatholytics; Plant Extracts; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic | 2014 |
Delta-9-tetrahydrocannabinol/cannabidiol (Sativex®): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
Topics: Adult; Cannabidiol; Cannabinoid Receptor Agonists; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Severity of Illness Index | 2014 |
Impact of Sativex(®) on quality of life and activities of daily living in patients with multiple sclerosis spasticity.
Topics: Activities of Daily Living; Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Outcome Assessment, Health Care; Plant Extracts; Quality of Life | 2014 |
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Plant Extracts | 2014 |
Medical marijuana for cancer.
Topics: Analgesics, Non-Narcotic; Antiemetics; Canada; Cannabidiol; Clinical Trials as Topic; Dronabinol; Drug Combinations; Evidence-Based Medicine; Humans; Medical Marijuana; Multiple Sclerosis; Neoplasms; Pain; Treatment Outcome; United Kingdom; United States | 2015 |
Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Marijuana Abuse; Substance Withdrawal Syndrome | 2015 |
Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety.
Topics: Acetylcysteine; Amines; Cannabidiol; Cyclohexanecarboxylic Acids; Dronabinol; Drug Combinations; Gabapentin; gamma-Aminobutyric Acid; Humans; Inappropriate Prescribing; Marijuana Abuse; Marijuana Smoking; Off-Label Use; Patient Safety; Practice Patterns, Physicians'; Psychotropic Drugs; Risk Assessment; Risk Factors; Treatment Outcome | 2015 |
Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Sleep; Visual Analog Scale | 2015 |
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Evidence-Based Medicine; Humans; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Treatment Outcome | 2015 |
Advances in the management of MS symptoms: real-life evidence.
Topics: Activities of Daily Living; Cannabidiol; Disease Management; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Product Surveillance, Postmarketing | 2015 |
Advances in the management of MS symptoms: recently proposed clinical management algorithms.
Topics: Algorithms; Cannabidiol; Clinical Trials as Topic; Disease Management; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2015 |
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.
Topics: Accidental Falls; Cannabidiol; Depression; Dronabinol; Drug Combinations; Germany; Humans; Marijuana Abuse; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Plant Extracts; Prospective Studies; Registries; Retrospective Studies; Spain; Switzerland; Treatment Outcome; United Kingdom | 2016 |
Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds.
Topics: Analgesics; Cannabidiol; Doping in Sports; Dronabinol; Drug Combinations; Gas Chromatography-Mass Spectrometry; Hair; Humans; Multiple Sclerosis; Plant Extracts; Workplace | 2016 |
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Topics: Amines; Analgesics; Baclofen; Cannabidiol; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Diazepam; Dronabinol; Drug Combinations; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Injections, Spinal; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Phenol | 2016 |
Evolution of multiple sclerosis spasticity-associated symptoms: latest data.
Topics: Administration, Oral; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle Relaxants, Central; Muscle Spasticity; Observational Studies as Topic; Plant Extracts; Randomized Controlled Trials as Topic | 2016 |
Cannabis and epilepsy: An ancient treatment returns to the fore.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Epilepsy; Europe; History, Ancient; Humans; India; Medical Marijuana; North America; Seizures | 2017 |
Pharmacology of cannabinoids in the treatment of epilepsy.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Epilepsy; Humans; Receptor, Cannabinoid, CB1; Treatment Outcome | 2017 |
Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Epilepsy; History, Ancient; Humans; Medical Marijuana | 2017 |
Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
Topics: Brain; Cannabidiol; Cannabinoids; Cannabis; Comprehension; Dronabinol; Drug Combinations; Epilepsy; Humans; Marijuana Smoking; Medical Marijuana; Neuroimaging | 2017 |
Cannabinoids in treatment-resistant epilepsy: A review.
Topics: Adult; Anticonvulsants; Cannabidiol; Cannabinoids; Child; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drug Resistant Epilepsy; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Medical Marijuana; Young Adult | 2017 |
Strokes are possible complications of cannabinoids use.
Topics: Adolescent; Adult; Brain; Brain Ischemia; Cannabidiol; Cannabinoids; Cannabis; Cohort Studies; Dronabinol; Drug Combinations; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Risk Factors; Stroke; Vasoconstriction; Young Adult | 2017 |
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
Topics: Administration, Oral; Animals; Cannabidiol; Cannabinoid Receptor Agonists; Dronabinol; Drug Combinations; Drug Design; Endocannabinoids; Humans; Plant Extracts; Signal Transduction | 2017 |
Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2017 |
Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Cannabidiol; Cannabis; Chronic Pain; Dronabinol; Drug Combinations; Humans; Medical Marijuana; Neuralgia; Pain Management; Pain, Postoperative; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation.
Topics: Cannabidiol; Clinical Trials as Topic; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Treatment Outcome | 2017 |
Practical considerations in medical cannabis administration and dosing.
Topics: Cannabidiol; Cannabis; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Drug Combinations; Humans; Inflammation; Medical Marijuana; Pain | 2018 |
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Pain; Quality of Life; Randomized Controlled Trials as Topic; Systematic Reviews as Topic | 2018 |
The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity.
Topics: Automobile Driving; Cannabidiol; Cognition; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents | 2018 |
Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Evidence-Based Medicine; Humans; Medical Marijuana; Multiple Sclerosis; Nervous System Diseases; Treatment Outcome | 2018 |
A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states.
Topics: Absorption, Physiological; Administration, Oral; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Drug Delivery Systems; Fasting; Gastrointestinal Tract; Humans; Mouth Mucosa; Saliva | 2019 |
Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Endocannabinoids; Humans; Nervous System Diseases; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2020 |
Marijuana, Lower Urinary Tract Symptoms, and Pain in the Urologic Patient.
Topics: Cancer Pain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Chronic Pain; Cystitis, Interstitial; Dronabinol; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Medical Marijuana; Multiple Sclerosis; Pain, Procedural; Pelvic Pain; Urinary Incontinence | 2020 |
Cannabis and cannabinoids in cancer pain management.
Topics: Analgesics, Opioid; Canada; Cancer Pain; Cannabidiol; Chronic Pain; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drug Evaluation, Preclinical; Humans; Medical Marijuana; Pain Management; Palliative Care; Quality of Life; Severity of Illness Index | 2020 |
Cannabis and multiple sclerosis.
Topics: Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Drug Combinations; Humans; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Pain; Urologic Diseases | 2020 |
Use of cannabidiol (CBD) for the treatment of chronic pain.
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Cross-Over Studies; Dronabinol; Drug Administration Routes; Drug Combinations; Drug Therapy, Combination; Humans; Treatment Outcome | 2020 |
A Critical Review of the Role of the Cannabinoid Compounds Δ
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Baclofen; Cannabidiol; Clinical Trials as Topic; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Approval; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Multiple Sclerosis; Spinal Cord; Treatment Outcome; United States; United States Food and Drug Administration | 2020 |
Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials.
Topics: Cannabidiol; Chronic Pain; Dronabinol; Drug Combinations; Humans; Neuralgia; Randomized Controlled Trials as Topic | 2021 |
Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports.
Topics: Analgesics, Opioid; Cannabidiol; Chronic Pain; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Registries | 2021 |
Review of Available Data for the Efficacy and Effectiveness of Nabiximols Oromucosal Spray (Sativex®) in Multiple Sclerosis Patients with Moderate to Severe Spasticity.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Observational Studies as Topic; Plant Extracts | 2021 |
Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity | 2022 |
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2022 |
Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials.
Topics: Adult; Cannabidiol; Dronabinol; Humans; Multiple Sclerosis; Muscle Spasticity; Randomized Controlled Trials as Topic; Treatment Outcome | 2023 |
46 trial(s) available for dronabinol and gw 1000
| Article | Year |
|---|---|
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Brachial Plexus Neuropathies; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Plant Extracts; Retrospective Studies; Sleep; Time Factors; Treatment Outcome | 2004 |
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
Topics: Administration, Oral; Analgesics; Arthritis, Rheumatoid; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Plant Extracts; Treatment Outcome | 2006 |
Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Analgesics; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Hyperesthesia; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Plant Extracts; Psychomotor Performance; Time Factors; Treatment Outcome | 2007 |
Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Topics: Administration, Oral; Administration, Sublingual; Adult; Aerosols; Analgesics, Opioid; Cannabidiol; Central Nervous System Diseases; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Mucosa; Multiple Sclerosis; Pain; Plant Extracts | 2007 |
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis.
Topics: Adult; Arachidonic Acids; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Endocannabinoids; Female; Humans; Lymphocytes; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Pain; Plant Extracts; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reflex, Stretch; Treatment Outcome; Young Adult | 2009 |
Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor.
Topics: Adult; Aged; Cannabidiol; Depression; Diabetic Neuropathies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Placebos; Plant Extracts; Quality of Life; Treatment Outcome | 2010 |
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis.
Topics: Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents; Plant Extracts; Severity of Illness Index; Time Factors; Treatment Outcome | 2010 |
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.
Topics: Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Plant Extracts; Urinary Bladder, Overactive | 2010 |
Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.
Topics: Adult; Cannabidiol; Cannabis; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; Mouth Mucosa; Plant Extracts; Young Adult | 2011 |
Subjective and physiological effects after controlled Sativex and oral THC administration.
Topics: Administration, Oral; Adult; Anxiety; Brain; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Combinations; Female; Heart Rate; Humans; Male; Mouth Mucosa; Plant Extracts; Psychotropic Drugs; Tissue Distribution; Young Adult | 2011 |
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.
Topics: Adult; Aged; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2011 |
A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use.
Topics: Adult; Cannabidiol; Cannabinoids; Cognition; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Drug Evaluation; Female; Humans; Illicit Drugs; Male; Marijuana Abuse; Middle Aged; Mouth Mucosa; Oral Sprays; Plant Extracts; Young Adult | 2011 |
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols).
Topics: Aged; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Muscle Spasticity; Placebos; Plant Extracts; Substance Withdrawal Syndrome | 2012 |
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Electrocardiography; Female; Humans; Longitudinal Studies; Male; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Pain Measurement; Phytotherapy; Plant Extracts; Sleep | 2013 |
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Topics: Administration, Oral; Administration, Sublingual; Adult; Cannabidiol; Cannabinoids; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Smoking; Medication Adherence; Mouth Mucosa; Plant Extracts; Saliva; Substance Abuse Detection; Young Adult | 2013 |
A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray.
Topics: Adolescent; Adult; Biological Availability; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Humans; Male; Middle Aged; Oral Sprays; Plant Extracts | 2013 |
A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain.
Topics: Analgesics; Antineoplastic Agents; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Neuralgia; Oral Sprays; Pain Measurement; Pilot Projects; Treatment Outcome | 2014 |
Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
Topics: Adult; Australia; Cannabidiol; Cannabinoid Receptor Agonists; Combined Modality Therapy; Double-Blind Method; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Marijuana Abuse; Middle Aged; Placebo Effect; Placebos; Psychotherapy; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome | 2014 |
Quantification of 11-nor-9-carboxy-δ9-tetrahydrocannabinol in human oral fluid by gas chromatography-tandem mass spectrometry.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Gas Chromatography-Mass Spectrometry; Humans; Plant Extracts; Saliva; Sensitivity and Specificity; Substance Abuse Detection; Tandem Mass Spectrometry | 2014 |
The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS.
Topics: Adult; Australia; Cannabidiol; Cannabinol; Chromatography, Liquid; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Multiple Sclerosis; Muscle Relaxants, Central; Oral Sprays; Pilot Projects; Plant Extracts; Saliva; Substance Abuse Detection; Tandem Mass Spectrometry | 2014 |
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Topics: Adult; Cannabidiol; Cerebral Cortex; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Electric Stimulation; Electromyography; Evoked Potentials, Motor; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Muscle Spasticity; Outcome Assessment, Health Care; Plant Extracts; Severity of Illness Index; Transcranial Magnetic Stimulation | 2015 |
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.
Topics: Adult; Brain; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Laser-Evoked Potentials; Male; Middle Aged; Multiple Sclerosis; Neuralgia; Pain Management; Pain Measurement; Plant Extracts; Transcranial Magnetic Stimulation | 2016 |
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.
Topics: Adult; Cannabidiol; Cannabis; Craving; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; Marijuana Smoking; Middle Aged; Plant Extracts; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome; Young Adult | 2016 |
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.
Topics: Adult; Amino Acids; Amyloid beta-Peptides; Biogenic Monoamines; Cannabidiol; Cross-Over Studies; Dronabinol; Drug Combinations; Endocannabinoids; Female; Fibroblasts; Follow-Up Studies; Gene Expression Regulation; Humans; Huntington Disease; Male; Mental Status Schedule; MicroRNAs; Middle Aged; Outcome Assessment, Health Care; Peptide Fragments; Pilot Projects; Plant Extracts; Plant Structures; Severity of Illness Index; tau Proteins | 2016 |
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Topics: Adult; Baclofen; Cannabidiol; Clonidine; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts | 2016 |
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Motor Neurons; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Pyramidal Tracts | 2017 |
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Interferon beta-1b; Leukocytes, Mononuclear; Male; Methylation; Middle Aged; Multiple Sclerosis, Chronic Progressive; Promoter Regions, Genetic; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2017 |
A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity.
Topics: Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Italy; Muscle Spasticity; Pilot Projects; Research Design; Stroke; Treatment Outcome | 2017 |
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain.
Topics: Analgesics; Analgesics, Opioid; Cancer Pain; Cannabidiol; Chemotherapy, Adjuvant; Chronic Pain; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Oral Sprays; Pain Measurement; Quality of Life; Treatment Outcome | 2018 |
Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology.
Topics: Administration, Oral; Adult; Biological Availability; Cannabidiol; Cross-Over Studies; Dronabinol; Drug Combinations; Gelatin; Healthy Volunteers; Humans; Male; Oral Sprays; Young Adult | 2018 |
The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis: Rationale, study design, and methodology.
Topics: Adolescent; Adult; Analgesics; Biomechanical Phenomena; Cannabidiol; Clinical Protocols; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neurological Rehabilitation; Oral Sprays; Robotics; Single-Blind Method; Treatment Outcome; Young Adult | 2017 |
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial.
Topics: Adult; Cannabidiol; Cognitive Behavioral Therapy; Craving; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; Middle Aged; Motivation; Pilot Projects; Placebos; Substance Withdrawal Syndrome; Young Adult | 2018 |
Palatability and oral cavity tolerability of THC:CBD oromucosal spray and possible improvement measures in multiple sclerosis patients with resistant spasticity: a pilot study.
Topics: Adult; Analgesics; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth; Multiple Sclerosis; Muscle Spasticity; Pilot Projects; Prospective Studies; Stomatitis; Taste; Taste Perception; Treatment Outcome | 2018 |
Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.
Topics: Adult; Australia; Cannabidiol; Cannabinoids; Cognition; Cognitive Behavioral Therapy; Combined Modality Therapy; Craving; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; New South Wales; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Treatment Outcome | 2018 |
Sativex
Topics: Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Prospective Studies; Treatment Outcome | 2019 |
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Topics: Adult; Aged; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Motor Neuron Disease; Muscle Spasticity; Quality of Life; Treatment Outcome | 2019 |
Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
Topics: Adult; Analgesics; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Myalgia; Oral Sprays; Outcome Assessment, Health Care; Severity of Illness Index | 2020 |
Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial.
Topics: Administration, Oral; Adolescent; Brain Injuries, Traumatic; Cannabidiol; Cerebral Palsy; Child; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Muscle Spasticity; Treatment Outcome | 2020 |
Cannabinoids in multiple sclerosis: A neurophysiological analysis.
Topics: Administration, Oral; Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Muscle Spasticity; Muscle, Skeletal; Pain; Pilot Projects; Treatment Outcome | 2020 |
Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial.
Topics: Australia; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; Marijuana Smoking; Substance-Related Disorders; Treatment Outcome | 2020 |
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Combinations; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oral Sprays; Precision Medicine; Survival Analysis; Temozolomide; Treatment Outcome | 2021 |
Short and long term effects of Nabiximols on balance and walking assessed by 3D-gait analysis in people with Multiple Sclerosis and spasticity.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Gait Analysis; Humans; Multiple Sclerosis; Muscle Spasticity; Walking | 2021 |
Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial.
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Comorbidity; Double-Blind Method; Dronabinol; Drug Combinations; Hallucinogens; Humans; Marijuana Abuse; Medical Marijuana; Pain; Sleep; Treatment Outcome | 2022 |
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol.
Topics: Aged; Cannabidiol; Chronic Pain; Dementia; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Oral Sprays; Psychomotor Agitation; Randomized Controlled Trials as Topic | 2022 |
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder.
Topics: Australia; Bayes Theorem; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Humans; Male; Marijuana Abuse; Pain; Substance-Related Disorders | 2022 |
Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Muscle Tonus; Randomized Controlled Trials as Topic; Spasm | 2023 |
110 other study(ies) available for dronabinol and gw 1000
| Article | Year |
|---|---|
GW-1000. GW Pharmaceuticals.
Topics: Administration, Oral; Analgesics; Animals; Biological Availability; Canada; Cannabidiol; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dronabinol; Drug Approval; Drug Combinations; Drug Evaluation, Preclinical; Drug Industry; Humans; Hyperalgesia; Investigational New Drug Application; Mice; Molecular Structure; Multiple Sclerosis; Patents as Topic; Peripheral Nervous System Diseases; Phytotherapy; Plant Extracts; Plant Preparations; Randomized Controlled Trials as Topic; Spinal Cord Injuries; Structure-Activity Relationship | 2004 |
Conditional okay for cannabis prescription drug.
Topics: Canada; Cannabidiol; Cannabis; Dronabinol; Drug Approval; Drug Combinations; Humans; Multiple Sclerosis; Neuralgia; Phytotherapy; Plant Extracts | 2005 |
Sublingual drug delivery during functional magnetic resonance imaging.
Topics: Administration, Sublingual; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Drug Delivery Systems; Humans; Magnetic Resonance Imaging; Plant Extracts | 2005 |
The use of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
Topics: Analgesics; Arthritis, Rheumatoid; Cannabidiol; Cannabis; Dronabinol; Drug Combinations; Humans; Pain; Plant Extracts; Treatment Outcome | 2006 |
New pain management options: drugs.
Topics: Analgesics, Opioid; Cannabidiol; Cannabinoids; Carbazoles; Chronic Disease; Dronabinol; Drug Combinations; Humans; Ibuprofen; Oxycodone; Oxymorphone; Pain; Plant Extracts; Serotonin Receptor Agonists; Tryptamines | 2007 |
Cannabis; adverse effects from an oromucosal spray.
Topics: Administration, Oral; Adult; Aerosols; Aged; Burns, Chemical; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Mucosa; Multiple Sclerosis; Pain; Phytotherapy; Plant Extracts | 2007 |
Willingness to pay for a treatment for pain in multiple sclerosis.
Topics: Administration, Oral; Administration, Sublingual; Adult; Aerosols; Aged; Aged, 80 and over; Analgesics, Opioid; Attitude to Health; Cannabidiol; Cost-Benefit Analysis; Decision Making; Dronabinol; Drug Combinations; Fees and Charges; Female; Humans; Insurance, Health; Interviews as Topic; Male; Middle Aged; Multiple Sclerosis; Pain; Patient Satisfaction; Plant Extracts; Surveys and Questionnaires | 2009 |
Cannabis based drug is licensed for spasticity in patients with MS.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Approval; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts | 2010 |
Cannabis-based treatment induces polarity-reversing plasticity assessed by theta burst stimulation in humans.
Topics: Adult; Animals; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Evoked Potentials, Motor; Female; Humans; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Middle Aged; Motor Cortex; Multiple Sclerosis; Neuronal Plasticity; Plant Extracts; Theta Rhythm; Transcranial Magnetic Stimulation | 2009 |
[Cannabis medicinal drugs. "Psychedelics" by prescription?].
Topics: Cannabidiol; Cannabis; Dronabinol; Drug Approval; Drug Combinations; Germany; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Palliative Care; Phytotherapy; Plant Extracts; Psychoses, Substance-Induced | 2010 |
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.
Topics: Animals; Cannabidiol; Cannabinoids; Caudate Nucleus; Cells, Cultured; Disease Models, Animal; Disease Progression; Dronabinol; Drug Combinations; Huntington Disease; Male; Neostriatum; Neuroprotective Agents; Phytotherapy; Plant Extracts; Putamen; Rats; Rats, Sprague-Dawley | 2011 |
Evaluate symptomatic therapy in MS: can clinical trials be fine-tuned?
Topics: Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2011 |
New pain drugs in pipeline, but challenges to usage remain.
Topics: Analgesics; Analgesics, Opioid; Antineoplastic Agents; Cannabidiol; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drugs, Investigational; Humans; Neoplasms; Neuralgia; Pain; Palliative Care; Plant Extracts | 2012 |
Sativex® in multiple sclerosis spasticity: a cost-effectiveness model.
Topics: Cannabidiol; Cost-Benefit Analysis; Dronabinol; Drug Combinations; Drug Costs; Drug Resistance; Germany; Humans; Markov Chains; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Quality-Adjusted Life Years; Severity of Illness Index; Spain | 2012 |
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report.
Topics: Administration, Mucosal; Adult; Cannabidiol; Dronabinol; Drug Combinations; Humans; Male; Plant Extracts; Quality of Life; Stiff-Person Syndrome; Surveys and Questionnaires; Treatment Outcome | 2013 |
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Cannabidiol; Caregivers; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Off-Label Use; Phytotherapy; Plant Extracts; Practice Patterns, Physicians'; Sleep; Surveys and Questionnaires; United Kingdom | 2013 |
Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.
Topics: Animals; Cannabidiol; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Combinations; Drug Therapy, Combination; Huntington Disease; Inflammation; Male; Malonates; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2012 |
Cost effectiveness of oromucosal cannabis-based medicine (Sativex®) for spasticity in multiple sclerosis.
Topics: Administration, Mucosal; Administration, Oral; Cannabidiol; Cost-Benefit Analysis; Dronabinol; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Markov Chains; Middle Aged; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Plant Extracts; Quality-Adjusted Life Years; Severity of Illness Index; United Kingdom | 2012 |
[Cannabis medicines in Norway--the basis for approval].
Topics: Cannabidiol; Dronabinol; Drug Approval; Drug Combinations; Drug Therapy, Combination; Humans; Multiple Sclerosis; Muscle Spasticity; Norway; Oral Sprays; Plant Extracts | 2012 |
Multiple sclerosis spasticity symptoms management. Endocannabinoid system modulator data beyond clinical trials. Foreword.
Topics: Anti-Dyskinesia Agents; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Modulators; Dronabinol; Drug Combinations; Drugs, Investigational; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2013 |
Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy.
Topics: Amyloidosis; Animals; Behavior, Animal; Biogenic Monoamines; Cannabidiol; Disease Models, Animal; Dopamine; Dronabinol; Drug Combinations; Frontotemporal Dementia; Glutathione; Humans; Male; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Neuroprotective Agents; Phytotherapy; Plant Extracts; Synaptic Transmission; Tauopathies | 2013 |
Overview of MS spasticity.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts; Practice Guidelines as Topic | 2014 |
Who benefits most from THC:CBD spray? Learning from clinical experience.
Topics: Activities of Daily Living; Adult; Aged; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Parasympatholytics; Plant Extracts; Quality of Life; Severity of Illness Index; Spinal Cord; Treatment Outcome | 2014 |
Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity.
Topics: Adult; Aged; Cannabidiol; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents; Plant Extracts; Prospective Studies; Severity of Illness Index; Sleep; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2014 |
[Cannabis - medicinal use].
Topics: Administration, Oral; Affect; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Germany; Humans; Marijuana Abuse; Marijuana Smoking; Medical Marijuana; Multiple Sclerosis; Pain, Intractable; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic; Receptors, Cannabinoid; Risk Factors; Wasting Syndrome | 2014 |
[Therapeutic use of cannabis derivatives].
Topics: Antiemetics; Cannabidiol; Dronabinol; Drug Combinations; Fibromyalgia; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Plant Extracts | 2014 |
Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis.
Topics: Age Factors; Amyotrophic Lateral Sclerosis; Analysis of Variance; Animals; Cannabidiol; Dronabinol; Drug Combinations; Endocannabinoids; Female; Gene Expression Regulation; Humans; Male; Mice, Transgenic; Phospholipase D; Plant Extracts; Receptors, Cannabinoid; Sex Factors; Spinal Cord; Superoxide Dismutase | 2014 |
Long-term effectiveness and safety of nabiximols (tetrahydrocannabinol/cannabidiol oromucosal spray) in clinical practice.
Topics: Adult; Aged; Analgesics; Cannabidiol; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Patient Satisfaction; Prospective Studies; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2014 |
Drug-resistant MS spasticity treatment with Sativex(®) add-on and driving ability.
Topics: Adult; Automobile Driving; Cannabidiol; Dronabinol; Drug Combinations; Female; Germany; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Pilot Projects; Plant Extracts | 2015 |
Should patient groups be more transparent about their funding?
Topics: Analgesics; Cannabidiol; Capital Financing; Charities; Dronabinol; Drug Combinations; Drug Industry; Humans; Multiple Sclerosis; Self-Help Groups; United Kingdom | 2014 |
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways.
Topics: Animals; Cannabidiol; Dronabinol; Drug Combinations; Endocannabinoids; Humans; Motor Cortex; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Muscle, Skeletal; Neural Pathways; Plant Extracts; Spinal Cord | 2014 |
Advances in the management of multiple sclerosis spasticity: recent clinical trials.
Topics: Affect; Cannabidiol; Clinical Trials, Phase III as Topic; Cognition; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Plant Extracts; Randomized Controlled Trials as Topic | 2014 |
Advances in the management of MS spasticity: recent observational studies.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Germany; Humans; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Observational Studies as Topic; Plant Extracts; Registries; Spain; United Kingdom | 2014 |
Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlights.
Topics: Activities of Daily Living; Cannabidiol; Cost of Illness; Dronabinol; Drug Combinations; Europe; Humans; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Plant Extracts; Quality of Life | 2014 |
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cannabidiol; Cannabinoids; Cannabinol; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Dronabinol; Drug Combinations; Humans; Male; Melanoma; Membrane Proteins; Mice; Mice, Nude; Microscopy, Confocal; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Plant Extracts; Proto-Oncogene Proteins B-raf; ras Proteins; Skin Neoplasms; Temozolomide | 2015 |
Sativex in the management of multiple sclerosis-related spasticity: role of the corticospinal modulation.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cerebral Cortex; Dronabinol; Drug Combinations; Evoked Potentials, Motor; Humans; Multiple Sclerosis; Muscle Spasticity; Neural Inhibition; Plant Extracts; Pyramidal Tracts; Sensorimotor Cortex; Transcranial Magnetic Stimulation | 2015 |
[Assessment of the effectiveness and safety of Sativex® in compassionate use].
Topics: Adult; Aged; Cannabidiol; Compassionate Use Trials; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Treatment Outcome | 2015 |
Cost-effectiveness of Sativex in multiple sclerosis spasticity: new data and application to Italy.
Topics: Cannabidiol; Cost of Illness; Cost-Benefit Analysis; Delivery of Health Care; Dronabinol; Drug Combinations; Humans; Italy; Markov Chains; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Quality-Adjusted Life Years | 2015 |
[A breakthrough for the treatment of spasticity in multiple sclerosis].
Topics: Cannabidiol; Cannabis; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts | 2015 |
A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.
Topics: Animals; Cannabidiol; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Drug Therapy, Combination; Mice; Mice, Inbred Strains; Multiple Sclerosis; Plant Extracts; Theilovirus | 2015 |
Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!
Topics: Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Middle Aged; Multiple Sclerosis; Self-Injurious Behavior; Suicidal Ideation | 2015 |
Walking improvements with nabiximols in patients with multiple sclerosis.
Topics: Adult; Biomechanical Phenomena; Cannabidiol; Dronabinol; Drug Combinations; Female; Gait Disorders, Neurologic; Humans; Male; Middle Aged; Multiple Sclerosis; Outcome Assessment, Health Care; Severity of Illness Index; Walking | 2015 |
A potted history.
Topics: Animals; Canada; Cannabidiol; Cannabinol; Cannabis; China; Dronabinol; Drug and Narcotic Control; Drug Approval; Drug Combinations; Endocannabinoids; Herbal Medicine; History, 16th Century; History, 17th Century; History, 19th Century; History, 20th Century; History, 21st Century; History, Ancient; History, Medieval; Humans; Medical Marijuana; Multiple Sclerosis; New Orleans; Phytotherapy; Plant Extracts; Plants, Medicinal; Receptors, Cannabinoid | 2015 |
Drug development: The treasure chest.
Topics: Allosteric Site; Analgesics; Animals; Cannabidiol; Cannabinoids; Cannabis; Child; Clinical Trials as Topic; Congresses as Topic; Dronabinol; Drug Combinations; Drug Discovery; Endocannabinoids; Humans; Mice; Plant Extracts; Receptors, Cannabinoid; Seizures; Terpenes | 2015 |
Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric study.
Topics: Adult; Cannabidiol; Cohort Studies; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Severity of Illness Index; Treatment Outcome | 2016 |
Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Prospective Studies | 2015 |
The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Drug Combinations; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Mice, Inbred C57BL; Neuroprotective Agents; Photomicrography; Piperidines; Plant Extracts; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Spinal Cord | 2015 |
Medical use of cannabis products: Lessons to be learned from Israel and Canada.
Topics: Canada; Cannabidiol; Cross-Cultural Comparison; Dronabinol; Drug and Narcotic Control; Drug Combinations; Germany; Humans; Insurance Coverage; Israel; Medical Marijuana; National Health Programs; Pain | 2016 |
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.
Topics: Adult; Amines; Baclofen; Calcium Channel Blockers; Cannabidiol; Cohort Studies; Cyclohexanecarboxylic Acids; Dronabinol; Drug Combinations; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Germany; Humans; Italy; Male; Medical Marijuana; Middle Aged; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Observational Studies as Topic; Oral Sprays; Plant Extracts; Pregabalin; Prospective Studies; Treatment Outcome | 2016 |
Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 Years.
Topics: Adult; Cannabidiol; Data Collection; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Medical Marijuana; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Plant Extracts; Prospective Studies; Registries; Treatment Outcome | 2016 |
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.
Topics: Administration, Oral; Adult; Aged; Analgesics; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Mucosa; Multiple Sclerosis; Muscle Spasticity; Reflex, Stretch; Treatment Outcome | 2016 |
The therapeutic use of cannabinoids: Forensic aspects.
Topics: Administration, Inhalation; Analgesics, Non-Narcotic; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Female; Forensic Toxicology; Humans; Male; Middle Aged; Multiple Sclerosis; Pain, Intractable | 2016 |
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
Topics: Administration, Oral; Cannabidiol; Dronabinol; Drug Combinations; Humans; Italy; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Safety | 2016 |
Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice.
Topics: Analgesics; Animals; Cannabidiol; Cisplatin; Dronabinol; Drug Combinations; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Plant Extracts | 2016 |
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis.
Topics: Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Drug Combinations; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Muscle Relaxants, Central; Muscle Spasticity; Trigeminal Neuralgia | 2016 |
Should we care about sativex-induced neurobehavioral effects? A 6-month follow-up study.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Follow-Up Studies; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2016 |
Cannabis and cannabinoids.
Topics: Administration, Oral; Analgesics; Anticonvulsants; Antiemetics; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Drug Interactions; Humans; Medical Marijuana; Parasympatholytics; Plant Extracts | 2016 |
The use of medical-grade cannabis in patients non-responders to Nabiximols.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Medical Marijuana; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Retrospective Studies; Treatment Outcome | 2016 |
Severe motor and vocal tics controlled with Sativex®.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Humans; Male; Psychiatric Status Rating Scales; Reproducibility of Results; Severity of Illness Index; Tics; Tourette Syndrome; Treatment Outcome; Videotape Recording | 2016 |
Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice.
Topics: Activities of Daily Living; Adult; Baclofen; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Plant Extracts; Prospective Studies; Quality of Life | 2016 |
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray.
Topics: Adult; Aged; Cannabidiol; Cannabinoid Receptor Modulators; Disability Evaluation; Dronabinol; Drug Combinations; Evoked Potentials, Motor; Female; Follow-Up Studies; H-Reflex; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Nasal Sprays; Neuromuscular Agents; Oral Sprays; Plant Extracts; Severity of Illness Index; Treatment Outcome | 2016 |
Country breakout session highlights.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Europe; Gait Disorders, Neurologic; Humans; Multiple Sclerosis; Muscle Spasticity | 2016 |
What is new in multiple sclerosis spasticity research? Poster session highlights.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity | 2016 |
Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study.
Topics: Brain; Cannabidiol; Cannabis; Dronabinol; Drug Combinations; Erotica; Humans; Hydrocortisone; Hypnotics and Sedatives; Libido; Magnetic Resonance Imaging; Nucleus Accumbens; Pilot Projects; Prolactin | 2017 |
[Compassionate use of cannabidiol in spray form for the treatment of spastic paraparesis in a patient with adrenomyeloneuropathy].
Topics: Adrenoleukodystrophy; Adult; Aerosols; Cannabidiol; Compassionate Use Trials; Dronabinol; Drug Combinations; Humans; Male; Paraparesis, Spastic | 2017 |
The effect of antioxidants on the long-term stability of THC and related cannabinoids in sampled whole blood.
Topics: Antioxidants; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Drug Combinations; Humans; Male | 2018 |
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).
Topics: Adult; Aged; Aged, 80 and over; Cannabidiol; Cost Sharing; Dronabinol; Drug Approval; Drug Combinations; Drug Costs; Drug Industry; Female; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Sclerosis; Multivariate Analysis; Muscle Spasticity; Parasympatholytics; Plant Extracts; Proportional Hazards Models; Registries; Regression Analysis; Severity of Illness Index; Young Adult | 2017 |
[European Union regulatory and quality requirements for botanical drugs and their implications for Chinese herbal medicinal products development].
Topics: Andrographis paniculata; Cannabidiol; Catechin; Dronabinol; Drug Approval; Drug Combinations; Drugs, Chinese Herbal; European Union; Herbal Medicine; Humans; Legislation, Drug; Plant Extracts | 2017 |
[Delta-9-tetrahydrocannabinol-cannabidiol in the treatment of spasticity in chronic spinal cord injury: a clinical experience].
Topics: Adult; Aged; Cannabidiol; Chronic Disease; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Muscle Spasticity; Spinal Cord Injuries; Treatment Outcome | 2017 |
Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.
Topics: Acoustic Stimulation; Administration, Inhalation; Administration, Oral; Analysis of Variance; Animals; Brain; Cannabidiol; Dronabinol; Drug Administration Routes; Drug Combinations; Exploratory Behavior; Gas Chromatography-Mass Spectrometry; Injections, Subcutaneous; Male; Prepulse Inhibition; Rats; Rats, Wistar; Time Factors; Tissue Distribution | 2017 |
Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
Topics: Antiemetics; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Dronabinol; Drug Approval; Drug Combinations; Europe; Germany; Humans; Israel; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Nausea; Pain Management; Palliative Care; Societies, Medical; Surveys and Questionnaires; Vomiting | 2018 |
PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.
Topics: Administration, Oral; Adult; Analgesics; Biological Availability; Cannabidiol; Cannabinoids; Capsules; Dronabinol; Drug Combinations; Drug Compounding; Drug Delivery Systems; Emulsions; Excipients; Humans; Male; Young Adult | 2018 |
Occurrence of illicit drugs in two wastewater treatment plants in the South of Italy.
Topics: Amphetamine; Amphetamines; Cannabidiol; Cocaine; Dronabinol; Drug Combinations; Humans; Illicit Drugs; Methamphetamine; Pyrrolidines; Sicily; Substance Abuse Detection; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2018 |
Police documentation of drug use in injured drivers: Implications for monitoring and preventing drug-impaired driving.
Topics: Accidents, Traffic; Adult; Aged; Alcohol Drinking; Automobile Driving; British Columbia; Cannabidiol; Cannabis; Documentation; Driving Under the Influence; Dronabinol; Drug Combinations; Ethanol; Female; Humans; Illicit Drugs; Law Enforcement; Male; Middle Aged; Police; Prevalence; Substance-Related Disorders; Trauma Centers; United States; Young Adult | 2018 |
Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.
Topics: Adult; Cannabidiol; Down-Regulation; Dronabinol; Drug Combinations; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Multiple Sclerosis | 2018 |
Balance worsening associated with nabiximols in multiple sclerosis.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Executive Function; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents; Postural Balance; Psychomotor Performance; Stroop Test | 2019 |
Cannabinoids for Treatment of Dystonia in Huntington's Disease.
Topics: Adolescent; Adult; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Dystonia; Female; Humans; Huntington Disease; Male; Treatment Outcome | 2018 |
Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited.
Topics: Cannabidiol; Cannabinoids; Down-Regulation; Dronabinol; Drug Combinations; Humans; Immunomodulation; Multiple Sclerosis | 2018 |
Cannabinoid-induced alteration of motor-evoked potentials (MEPs) prior to intradural spinal tumor removal: a nasty surprise.
Topics: Analgesics; Cannabidiol; Child; Dronabinol; Drug Combinations; Evoked Potentials, Motor; Female; Humans; Intraoperative Neurophysiological Monitoring; Neurofibromatosis 1; Spinal Cord Neoplasms | 2018 |
A Survey on the Medical Use of Cannabis in Europe: A Position Paper.
Topics: Analgesics; Cannabidiol; Dronabinol; Drug Combinations; Europe; Humans; Internet; Medical Marijuana; Surveys and Questionnaires | 2018 |
Evidence for treatment of spasticity in motor neuron disease.
Topics: Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Motor Neuron Disease; Muscle Spasticity | 2019 |
Tetrahydrocannabinol: cannabidiol oromucosal spray for treating symptoms of multiple sclerosis spasticity: newest evidence.
Topics: Administration, Mucosal; Cannabidiol; Cannabinoid Receptor Modulators; Congresses as Topic; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Observational Studies as Topic; Oral Sprays; Randomized Controlled Trials as Topic; Societies, Medical | 2019 |
Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from randomized clinical trials.
Topics: Administration, Mucosal; Affect; Cannabidiol; Cannabinoid Receptor Modulators; Cognition; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Outcome and Process Assessment, Health Care; Randomized Controlled Trials as Topic | 2019 |
Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from postapproval pragmatic studies.
Topics: Administration, Mucosal; Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Drug Approval; Drug Combinations; Humans; Italy; Multiple Sclerosis; Muscle Spasticity; Observational Studies as Topic; Oral Sprays; Pragmatic Clinical Trials as Topic; Registries | 2019 |
Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study.
Topics: Adolescent; Adult; Aged; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Duration of Therapy; Female; Fibromyalgia; Humans; Male; Manitoba; Medication Adherence; Middle Aged; Neoplasms; Osteoarthritis; Prescription Drugs; Retrospective Studies; Social Class; Substance-Related Disorders; Young Adult | 2019 |
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).
Topics: Cannabidiol; Combined Modality Therapy; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Physical Therapy Modalities; Withholding Treatment | 2019 |
Cannabis research round-up.
Topics: Cannabidiol; Cannabis; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Motor Neuron Disease | 2019 |
Clinical Significance and Outcomes in Trial of Nabiximols for Treatment of Cannabis Dependence.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Marijuana Abuse | 2020 |
Clinical Significance and Outcomes in Trial of Nabiximols for Treatment of Cannabis Dependence.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Marijuana Abuse | 2020 |
Clinical Significance and Outcomes in Trial of Nabiximols for Treatment of Cannabis Dependence-Reply.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Marijuana Abuse | 2020 |
Source of cannabinoids: what is available, what is used, and where does it come from?
Topics: Anticonvulsants; Cannabidiol; Cannabinoids; Child; Child, Preschool; Dronabinol; Drug Combinations; Epilepsies, Myoclonic; Epilepsy; Humans; Lennox Gastaut Syndrome; Plant Extracts; Seizures | 2020 |
Predictors of Nabiximols (Sativex
Topics: Adult; Analgesics, Non-Narcotic; Cannabidiol; Cognitive Dysfunction; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Patient Compliance; Patient Dropouts; Retrospective Studies; Severity of Illness Index | 2020 |
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis.
Topics: Adult; Cannabidiol; Cost-Benefit Analysis; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Quality of Life; Quality-Adjusted Life Years | 2020 |
Nabiximols plus robotic assisted gait training in improving motor performances in people with Multiple Sclerosis.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Gait; Humans; Multiple Sclerosis; Robotic Surgical Procedures | 2020 |
Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot study.
Topics: Adult; Aged; Cannabidiol; Cognition; Cognition Disorders; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuropsychological Tests; Oral Sprays; Parasympatholytics; Pilot Projects; Prospective Studies; Single-Blind Method; Young Adult | 2020 |
Efficacy of cannabinoids for treating paediatric spasticity in cerebral palsy or traumatic brain injury: what is the evidence?
Topics: Brain Injuries, Traumatic; Cannabidiol; Cannabinoids; Cerebral Palsy; Child; Dronabinol; Drug Combinations; Humans; Medicine; Muscle Spasticity; Safety | 2020 |
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Patient Compliance; Prospective Studies; Time Factors; Treatment Outcome; Withholding Treatment | 2020 |
[Nabiximols as a substitute for cannabis].
Topics: Analgesics; Cannabidiol; Cannabis; Clinical Trials as Topic; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; Nasal Sprays; Substance Withdrawal Syndrome | 2020 |
Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study.
Topics: Cannabidiol; Computer Simulation; COVID-19; Data Interpretation, Statistical; Dronabinol; Drug Combinations; Endpoint Determination; Humans; Mental Health; Physical Distancing; Randomized Controlled Trials as Topic; Research Design; Sample Size; Severity of Illness Index; Tic Disorders; Tics; Time Factors; Tourette Syndrome; Treatment Outcome | 2021 |
Cannabinoids in glioblastoma multiforme-hype or hope?
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Cell Proliferation; Cell Survival; Clinical Trials, Phase I as Topic; Dronabinol; Drug Combinations; Glioblastoma; Humans; Oral Sprays; Temozolomide; Treatment Outcome | 2021 |
Effect of nabiximols on Goal Attainment Scale scores in patients with treatment-resistant multiple sclerosis spasticity.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Goals; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Pilot Projects; Plant Extracts; Proof of Concept Study; Prospective Studies; Quality of Life; Treatment Outcome | 2021 |
Nabiximols and botulinum toxin injections for patients with multiple sclerosis: efficacy on spasticity and spasms in a single-centre experience.
Topics: Botulinum Toxins; Botulinum Toxins, Type A; Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Retrospective Studies; Spasm; Treatment Outcome | 2021 |
Extensive phytocannabinoid profiles of seized cannabis and cannabis-based medicines - Identification of potential distinguishing markers.
Topics: Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Drug Combinations; Humans; Mass Spectrometry; Medical Marijuana; Principal Component Analysis | 2021 |
Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses.
Topics: Belgium; Cannabidiol; Cost-Benefit Analysis; Dronabinol; Drug Combinations; Humans; Monte Carlo Method; Muscle Spasticity; Quality-Adjusted Life Years | 2021 |
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience.
Topics: Belgium; Cannabidiol; Cannabinoids; Dronabinol; Drug Administration Schedule; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Patient Reported Outcome Measures; Plant Extracts; Quality of Life; Retrospective Studies; Severity of Illness Index | 2021 |
Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Humans; Male; Tics; Tourette Syndrome | 2021 |
Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry.
Topics: Adult; Analgesics; Analgesics, Opioid; Back Pain; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Neuralgia; Registries; Retrospective Studies | 2022 |
Possible opioid-saving effect of cannabis-based medicine using individual-based data from the Norwegian Prescription Database.
Topics: Adult; Aged; Analgesics; Analgesics, Opioid; Cannabidiol; Databases, Factual; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Norway; Opioid-Related Disorders; Practice Patterns, Physicians' | 2022 |
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome'.
Topics: Cannabidiol; Central Nervous System Diseases; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Cramp; Muscle Spasticity; Pain; Spasm; Treatment Outcome | 2022 |
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Humans; Male; Multiple Sclerosis; Muscle Spasticity | 2023 |